Sanming First Hospital
Sanming First Hospital
Sanming, Fujian, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC | Muscle Invasive Bladder Cancer (MIBC) | Recruiting | Phase 2 | 2025-12-22 | NCT07296705 |